SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003485
Filing Date
2021-11-08
Accepted
2021-11-08 16:34:33
Documents
99
Period of Report
2021-10-03

Document Format Files

Seq Description Document Type Size
1 10-Q ocdx-20211003.htm   iXBRL 10-Q 3925983
2 EX-31.1 ocdx-ex31_1.htm EX-31.1 20372
3 EX-31.2 ocdx-ex31_2.htm EX-31.2 20054
4 EX-32.1 ocdx-ex32_1.htm EX-32.1 10813
5 EX-32.2 ocdx-ex32_2.htm EX-32.2 10777
  Complete submission text file 0000950170-21-003485.txt   14829603

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocdx-20211003_def.xml EX-101.DEF 354330
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocdx-20211003_cal.xml EX-101.CAL 61975
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocdx-20211003_pre.xml EX-101.PRE 525127
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocdx-20211003.xsd EX-101.SCH 83046
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocdx-20211003_lab.xml EX-101.LAB 554215
11 EXTRACTED XBRL INSTANCE DOCUMENT ocdx-20211003_htm.xml XML 3359076
Mailing Address 1001 ROUTE 202 RARITAN NJ 08869
Business Address 1001 ROUTE 202 RARITAN NJ 08869 (908) 218-8000
Ortho Clinical Diagnostics Holdings plc (Filer) CIK: 0001828443 (see all company filings)

IRS No.: 981151819 | State of Incorp.: X0 | Fiscal Year End: 0102
Type: 10-Q | Act: 34 | File No.: 001-39956 | Film No.: 211388487
SIC: 2835 In Vitro & In Vivo Diagnostic Substances